ImageneBio, Inc. Common Stock (NASDAQ: IMA) last traded at $5.51, down 1.78% on the session. The quote above updates while this page is open; the figures below are drawn from ImageneBio, Inc. Common Stock’s own filings and are restated only when a new one is published.
ImageneBio, Inc. Common Stock trades on NASDAQ under the ticker IMA. Its market capitalisation is $62.55 million.
Valuation measures for ImageneBio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $62.55M |
|---|---|
| Enterprise value | -$22.16M |
| Price / sales | 78.18 |
| Price / book | 0.44 |
| Beta | 0.95 |
Trailing-twelve-month figures tagged in ImageneBio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $800.0K |
|---|---|
| Net income (TTM) | -$52.48M |
| Operating margin | -7370.13% |
| Return on equity | -36.94% |
| Cash | $94.68M |
Range and volume for IMA over the past 52 weeks.
| 52-week high | $14.34 |
|---|---|
| 52-week low | $3.94 |
| Volume | 19.7K |
| Average volume | 12.1K |
| Previous close | $5.61 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.